Description
Descripción clínica en INGLÉS: indicaciones en CCR, eficacia general, contexto de uso (3-4 frases)
Mechanism of Action
Mecanismo de acción detallado en INGLÉS (2-3 frases, técnico pero claro)
Side Effects
Efectos secundarios principales en INGLÉS separados por punto y coma
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
NCT06162221
Phase 1
Recruiting
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
United States, Australia, Denmark, France, Germany, Greece, Italy, Netherlands,
NCT05462717
Phase 1
Active, not recruiting
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
United States, Australia, Czechia, France, Italy, Malaysia, Poland, Serbia, Sing
Quick Info
| Category | Other Medications |
 EMA Status | Not submitted to EMA |
 Spain Access | Not available |
| Clinical Trials | 2 |
Related Medications
Uracil
Other Medications
779 trials
Leucovorin
Other Medications
639 trials
Paclitaxel
Other Medications
53 trials
Cyclophosphamid
Other Medications
50 trials
Cyclophosphamide
Other Medications
49 trials
Trifluridine
Other Medications
47 trials
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.